Skip to main content

PMA-qPCR for viability and phenotypic antibiotic susceptibility testing of Acinetobacter baumannii to four mechanistically distinct antibiotics in bronchoalveolar lavage

In brief

A lavage PCR test detects viable A. baumannii in 80 minutes

In 59 bronchoalveolar lavage samples, the viability-focused PCR assay detected Acinetobacter baumannii with sensitivities of 91% and 95% and specificities of 97% and 92% against targeted sequencing. Antibiotic susceptibility results followed in 125 minutes, but agreement varied by drug, from 100% for polymyxin B to 85% for meropenem, so performance needs further validation.

Journal
Journal of global antimicrobial resistance (Q2)
Published
16 November 2026
Study design
Unclassified
Evidence level
Level 5, Expert Opinion (CEBM 5)
Authors
Jun Luo, Youyao Xu, Min Liu, Xiaoling Zheng, Wen Ai, Lu Han, et al.
PMID
43039314
DOI
10.1016/j.jgar.2026.11.005

Why clinicians should know about it

  • Picked for Microbiology (medical) (top studies of the week, 22 November 2026): Rapid viable-pathogen detection and phenotypic susceptibility testing in BAL

Abstract

OBJECTIVE: Due to its resistance to broad-spectrum antibiotics, Acinetobacter baumannii has become a predominant nosocomial pathogen. Thus, precise detection of viable bacteria and antimicrobial resistance is urgently needed. METHODS: A PMA-qPCR assay was developed for the rapid, direct detection of viable Acinetobacter baumannii and antimicrobial susceptibility determination from bronchoalveolar lavage fluid, with its performance validated against targeted next-generation sequencing and culture. RESULTS: The assay demonstrated a detection limit of 1200 CFU/mL. In 59 clinical bronchoalveolar lavage fluid specimens, PMA-qPCR achieved a sensitivity of 90.91% (95% CI: 72.19 to 97.47) and 95.45% (95% CI: 78.2 to 99.19), and a specificity of 97.3% (95% CI: 86.18 to 99.52) and 91.89% (95% CI: 78.7 to 97.2) within 80 minutes, respectively, compared with targeted next-generation sequencing. After 45 minutes of antibiotic incubation, susceptibility testing for multiple antimicrobial agents was completed within 125 minutes. The performance of antimicrobial susceptibility testing is reliant on the mechanistic profile of the antibiotic. The highest overall agreement was observed for polymyxin B [100% (95% CI: 83.89 to 100)], which acts by targeting the bacterial cell membrane. Amikacin and ciprofloxacin, which inhibit protein synthesis and DNA replication/transcription respectively, yielded an overall agreement of 90% (95% CI: 69.9 to 97.21). By contrast, meropenem, a cell wall-active antibiotic, achieved the lowest overall agreement at 85% (95% CI: 63.96 to 94.76). CONCLUSION: Collectively, our results validate that PMA-qPCR serves as a rapid and reliable assay for the detection of viable Acinetobacter baumannii and antimicrobial resistance, thereby facilitating precise clinical decision-making.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.